Acer Therapeutics Inc (NASDAQ:ACER)

0.87
BATS BZX Real-Time Price
As of 3:01pm ET
 -0.0037 / -0.42%
Today’s Change
0.65
Today|||52-Week Range
4.56
-65.34%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$22.0M

Company Description

Acer Therapeutics, Inc. is a pharmaceutical company, which engages in the acquisition, development, and commercialization of therapies for medical needs. Its product pipeline includes Olpruva, Edsivo, and ACER-801. Olpruva is used for the treatment of urea cycle disorders. Edsivo is a type of celiprolol used in treating Vascular Ehlers-Danlos syndrome. ACER-001 treats menopausal related Vasomotor symptoms. The company was founded by Chris Schelling in December 2013 and is headquartered in Newton, MA.

Contact Information

Acer Therapeutics, Inc.
One Gateway Center
Newton Massachusetts 02458
P:(844) 902-6100
Investor Relations:
844

Employees

Shareholders

Individual stakeholders29.35%
Mutual fund holders2.59%
Other institutional19.22%

Top Executives

Christopher SchellingPresident, Chief Executive Officer & Director
Tanya HaydenChief Operating Officer
Harry S. PalminChief Financial Officer
Adrian QuartelChief Medical Officer
John M. KloppChief Technical Officer